ArticleOncoTargets and therapy2019

Induction Of XLF And 53BP1 Expression Is Associated With Temozolomide Resistance In Glioblastoma Cells.

Tongxia Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.